Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Medical Marijuana Edibles Veterans topic
No spam. Unsubscribe anytime.
Senate hears bill on medical‑marijuana edibles, veterans attestation, licensing and telehealth adjustments
Summary
Senator Kristin Rohrer, R‑District 27, presented Senate Bill 22‑94, proposing a 5‑mg per‑edible cap, new licensing terms, a veteran attestation option and telehealth and nonresident transfer provisions for the medical‑marijuana program.
Senator Kristin Rohrer, R‑District 27, presented Senate Bill 22‑94, the second of two medical‑marijuana bills, which includes limits on edible cannabinoid products, licensure changes, a veterans attestation process and other program adjustments.
Rohrer described the bill’s key items: a 5‑milligram THC‑per‑edible limit (lower than a House bill that included a 10‑mg per‑piece cap), authorization for the Department of Health and Human Services to set a maximum purchase quantity, and a one‑year $25 initial registration with a subsequent two‑year $40 renewal option to reduce administrative burden for participants and the department.
Casey Newman, CEO of Pure Dakota Health, testified for the industry and described product specifications: individually portioned edibles roughly 7/8 by 7/8 inch, child‑resistant packaging with tamper‑evident seals and a molded THC symbol in each piece. Newman recommended more conservative purchase and possession limits (he described a potential 310‑mg daily cap and a 500‑mg possession limit as conservative proposals) and said telehealth and reduced licensing burdens would help rural patients.
On veterans, Rohrer and Jason Wall of the Department of Health and Human Services said VA medical records are often difficult to obtain and that a sworn attestation would allow veterans to certify eligibility without the paperwork delays that currently frustrate many applicants. Wall said about 260 veterans use the program’s current accommodation process and that the program has about 1,300 veterans registered overall; he testified the attestation would reduce delays and administrative burden.
Witnesses also cautioned that full recreational legalization in neighboring jurisdictions, including Minnesota, and regulatory changes could shift market demand across borders and affect in‑state dispensaries.
The hearing ended with no committee vote recorded; proponents requested the committee consider amendments (for example, adding a maximum purchase quantity) and noted potential fiscal and operational impacts for program staff and dispensaries if neighboring markets expand recreational access.
